Home
News
- 1 MET stock price persists in a bullish trend and follows a higher highs pattern.
- 2 The daily chart illustrates a positive crossover of the 50-day and 200-day EMA indicating strength over the charts.
Metlife, Inc. stock persists in a bullish trend and delivers a positive outlook. The stock forms a higher high pattern over the daily chart. Currently, the price has slipped near the 50-day EMA which may act as a support for the price.
The daily chart shows that the recent selloff has taken the MET stock price near the 50-day EMA from where it might receive some buying volume. The stock has been maintaining an optimistic price trend in the current quarter and might try to maintain the same.
However, the breakdown of the price below the EMA may add some selling pressure in the short term and the price may decline to the lower support levels. Metlife stock price currently trades at $62.90 and has a market cap of 47.2 Billion.
The volume analysis shows that Metlife has a 24-hour volume of 3.48 Million which is below the average 10-day volume of 4.46 Million. The company has a good dividend yield of 3.31%.
MET stock option-chain analysis states that the current implied volatility in the market is 25.81% with a decrement of 0.01% in the last trading session. The at-the-money strike price has 41 open contracts on the PUT side and 121 open contracts on the CALL side indicating the dominance of sellers at the CMP.
MET Stock Recent News
Recently, MetLife Inc., MET introduced its 360Health service in Nepal and its 360Future product in Korea on Monday. 360Health is a digital healthcare service that tracks heart rate, blood pressure, and other health metrics.
The 360Health service is already offered in five other countries. 360Future is a product that offers retirement plans, including asset management, health management, and life care. Customers in Korea can use the MetLife One app to access it.
MET Stock Price May Bounce Back from 50-day EMA
The daily price chart shows that the MET stock price trades above 50 and 200-day EMA indicating a strength in the price trend. The overall technical opinion rating including RSI and MACD signals a 48% “buy” rating with a weakening short-term outlook on maintaining the current direction.
Conclusion
Metlife Inc. stock is in a bullish trend and forms a higher high pattern on the daily chart. The price is near the 50-day EMA which may act as a support. The breakdown of the EMA may trigger selling pressure. The stock trades at $62.90 and has a good dividend yield of 3.31%. MetLife MET launched its 360Health service in Nepal and its 360Future product in Korea on Monday. 360Health is a digital healthcare service and 360Future is a retirement plan product. Customers in Korea can access them through the MetLife One app.
Technical Levels
- Support levels: $61.08 and $58.66.
- Resistance levels: $64.68 and $66.84.
Disclaimer
The views and opinions stated by the author, or any people named in this article, are for informational purposes only and do not establish financial, investment, or other advice. Investing in or trading crypto or stock comes with a risk of financial loss.
With a background in journalism, Ritika Sharma has worked with many reputed media firms focusing on general news such as politics and crime. She joined The Coin Republic as a reporter for crypto, and found a great passion for cryptocurrency, Web3, NFTs and other digital assets. She spends a lot of time researching and delving deeper into these concepts around the clock, and is a strong advocate for women in STEM.
